Franck Gallardo
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Oncolytic viruses and pancreatic cancer: rethinking the approach to overcome therapeutic resistance
Journal: Medecine sciences : M/S
Published: July 17, 2026
Plant virus-corrole adducts as bio-inspired antiviral nanomaterials.
Journal: Nanoscale
Published: July 17, 2026
SG33, a Vaccine Strain of Myxoma Virus with Oncolytic Potential, Exploits Macropinocytosis and Clathrin-Mediated Endocytosis for Entry into Pancreatic Cancer Cells.
Journal: Human gene therapy
Published: April 10, 2026
Tracking replicating HPV genomes in proliferating keratinocytes.
Journal: mBio
Published: July 08, 2025
Antiviral Activity of the Acyclic Nucleoside Phosphonate Prodrug LAVR-289 against Poxviruses and African Swine Fever Virus.
Journal: ACS infectious diseases
Published: May 22, 2025
LAVR-289, an Orally Bioavailable Inhibitor of Adenovirus Replication In Vitro and In Vivo.
Journal: ACS infectious diseases
Published: May 19, 2025
LAVR-289, an Acyclo-Nucleoside Phosphonate, Has Broad-Spectrum Activity against Herpesviruses.
Journal: ACS infectious diseases
Published: May 17, 2025
Use of ANCHOR viruses to validate radiative, physical and chemical decontamination systems in operational conditions.
Journal: The Journal of hospital infection
Published: May 06, 2025
Tracking Replicating HPV Genomes in Proliferating Keratinocytes.
Journal: bioRxiv : the preprint server for biology
Published: April 01, 2025
Tracking of single virus: Dual fluorescent labeling of pseudorabies virus for observing entry and replication in the N2a cells.
Journal: Veterinary microbiology
Published: January 03, 2025
Lyotropic liquid crystal emulsions of LAVR-289: Influence of internal mesophase structure on cytotoxicity and in-vitro antiviral activity.
Journal: International journal of pharmaceutics
Published: May 27, 2024
Last Updated: 09/26/2026